Evidence map›Paper›PMID 33650299›Full record

Trial reportClinical and translational science2021

Effect of selenium on thyroid autoimmunity and regulatory T cells in patients with Hashimoto's thyroiditis: A prospective randomized-controlled trial.

Yifang Hu, Wenwen Feng, Huanhuan Chen, He Shi, Lin Jiang, Xuqin Zheng, Xiaoyun Liu, Wensong Zhang, Yaoqi Ge, Yun Liu and 1 more

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Clinical and translational science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 2 pooled it
8.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 2 syntheses or guidelines pooled it, 85 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Heterozygous pathogenic variants inOpen life sciences · 2026
    Article
  13. Review
  14. Article
  15. Article
  16. Selenium-enrichedFrontiers in fungal biology · 2026
    Article
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Yifang HuDepartment of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Wenwen FengDepartment of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Huanhuan ChenDepartment of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
He ShiDepartment of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Lin JiangDepartment of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Xuqin ZhengDepartment of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Xiaoyun LiuDepartment of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Wensong ZhangDepartment of Pharmacy, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Yaoqi GeDepartment of Geriatrics, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Yun LiuDepartment of Geriatrics, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Dai CuiDepartment of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Nanjing Medical University · CNJiangsu Province Hospital · CN

Funding

China Health Promotion FoundationMinistry of Science and Technology of China 2018YFC1314900Ministry of Science and Technology of China 2018YFC1314901Six Talent Peaks Project in Jiangsu Province 2016-WSN-023
6 · The paper itself

Abstract

Selenium (Se) is an essential trace element in human. Recent studies of Se supplementation on the effect of Hashimoto's thyroiditis (HT) have been reported, but the exact benefit is unclear as well as the underlying immunologic mechanism. We aimed to evaluate the clinical effect of Se supplement in patients with HT, and explore the potential mechanism against thyroid autoimmunity. A prospective, randomized-controlled study was performed in patients with HT assigned to two groups. Se-treated group (n = 43) received selenious yeast tablet (SYT) for 6 months, whereas no treatment in control group (n = 47). The primary outcome is the change of thyroid peroxidase antibody (TPOAb) or thyroglobulin antibody (TGAb). Second, thyroid function, urinary iodine, Se, Glutathione peroxidase3 (GPx3), and Selenoprotein P1 (SePP1) levels were measured during the SYT treatment. Meanwhile, regulatory T cells (Tregs) and their subsets activated Tregs (aTregs), resting Tregs, and secreting Tregs, as well as Helios and PD-1 expression on these cells were also detected. The results showed that SYT treatment significantly decreased TPOAb, TGAb, and thyroid stimulating hormone (TSH) levels, accompanied with the increased Se, GPx3, and SePP1, compared with the control group. Subgroup analysis revealed that subclinical HT may benefit more from this treatment in the decrease of TSH levels by interaction test. Moreover, the percentage of aTregs, Helios/Tregs, and Helios/aTregs were significantly higher in the Se-treated group than control. In conclusion, Se supplementation may have a beneficial effect on thyroid autoantibodies and thyroid function by increasing the antioxidant activity and upregulating the activated Treg cells.

Indexed as

AdultAutoantibodiesDietary SupplementsFemaleHashimoto DiseaseHumansLymphocyte ActivationMaleMiddle AgedProspective StudiesSeleniumThyroid GlandT-Lymphocytes, RegulatoryTrace ElementsTreatment OutcomeAutoantibodiesSeleniumthyroid microsomal antibodiesTrace Elements

Identifiers

PMID33650299
PMCPMC8301566
OpenAlexW3134656802

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.